©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.

Slides:



Advertisements
Similar presentations
Team/Organization Name Background and structure Location Brief system information (type, size) Pilot population.
Advertisements

CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.
Summary Prepared by Melvyn Rubenfire, MD
Paul Muntner, Lisandro D Colantonio, Mary Cushman, David C Goff Jr
Derby Hospitals moving forward in the 21 st Century …. Dianne Prescott, Director of Strategy & Partnerships Future Strategy.
NCEP ATP IV GuidelineS: 2013 Update
National Quality Strategy Overview August National Quality Strategy Introduction The Affordable Care Act (ACA) requires the Secretary of the Department.
1 OA Action Alliance Physical Activity Workgroup July 7, 2011.
Donald T. Simeon Caribbean Health Research Council
Lipid Management in 2015: Risk & Controversies
By Apurva D. Shah, FACC Northside Heart and Vascular Institute.
1 Day of Research and Engagement for the Community Markham, IL March 1, 2014 Aingyea Kellom, MPA Program Associate, Patient Engagement Ambassador Program.
Engaging Patients and Other Stakeholders in Clinical Research
National Coalition for Cancer Survivorship Meeting, Washington DC November 13, 2014 Steven Clauser, PhD, MPA Program Director, Improving Healthcare Systems.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
©PPRNet 2014 Designing a PPRNet PCORI Application to Improve Adherence to USPSTF Grade D Recommendations for Cancer Screening.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Sue Sheridan, Acting Director, Patient.
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
CADTH Therapeutic Reviews
Results from 2014 NHSRU-KTEP Environmental Scan Prepared for Policy to Practice – Investing in Your Workforce September 15, 2014 Prepared by the Nursing.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Module 3. Session DCST Clinical governance
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Approach and Key Components. The Goal of Cities for Life: To help community groups and primary care providers create an environment that facilitates and.
IMPROVING DIABETES MANAGEMENT IN PRIMARY CARE
QSEN Primer Or, “QSEN in a Nutshell” 1.  1999—Institute of Medicine published “To Err is Human”  Determined errors have an effect on both patient satisfaction.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
PARTNERSHIP TO IMPROVE DEMENTIA CARE THE OHIO APPROACH.
CTxCPCRN Central Texas Cancer Prevention and Control Research Network Kick Off Grantee Meeting Atlanta, Georgia October 15-16, 2009.
A GP for Me Making it Work in Victoria November 27, 2013.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
CHAPTER 28 Translation of Evidence into Nursing Practice: Evidence, Clinical practice guidelines and Automated Implementation Tools.
Lawrence B. Sadwin Friends of the World Heart Federation Foundation Moving Ahead: Leveraging Knowledge & Action to Improve Healthcare Quality. AHRQ 2012.
Unit 9: Evaluating a Public Health Surveillance System #1-9-1.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Self-Management Support Strategies for Improving your Patients’ CVD Risk Bonnie Jortberg PhD, RD, CDE Robyn Wearner RD, MA Department of Family Medicine.
Stakeholder Engagement for Patient-Centered Outcomes Research Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
American Association of Colleges of Nursing. © All Rights Reserved. This program generously funded by the Robert Wood Johnson Foundation Evidence-Based.
Presentation Developed for the Academy of Managed Care Pharmacy
Module 3: Orientation to Research
Clinical Studies Continuum
Safi U. Khan MD; John Pamula MD
What is a Learning Collaborative?
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
MULTIMORBIDITY: THE MOST COMMON CHRONIC CONDITION
Neil J. Stone et al. JACC 2014;63:
Presentation Developed for the Academy of Managed Care Pharmacy
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Provider and Member Education in Managed Care Pharmacy
Jason Gerson, PhD Clinical Effectiveness and Decision Science
PCORI Research Priorities and Relevant Examples
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Contemporary Evidence-Based Guidelines
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Webinar #3P: How you can contribute to research
Module 5: Formulating Research Questions
Preventative Cardiology
NICE has many methods and processes
NICE resources for STPs: MECC
Patient-Centered Outcomes Research Institute (PCORI)
Presentation Developed for the Academy of Managed Care Pharmacy
Data as the Passenger: The Importance of Identifying What Data Matters to the Community Courtney Clyatt Program Officer, Pipeline to Proposal Awards/Engagement.
Presentation transcript:

©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment of Blood Cholesterol

©PPRNet 2014 GOALS Update members on recently submitted PCORI application Engage participants in planning PPRNet’s approach to patient-centered and patient engaged research in implementation of cholesterol guidelines

©PPRNet 2014 PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE Independent, non-profit organization authorized under Affordable Care Act “Fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions” Funded >$200 million in research in 2013

©PPRNet 2014

PCORI PRIORITIES Research will help answer these questions: “Given my personal characteristics, conditions and preferences, what should I expect will happen to me?” “What are my options and what are the potential benefits and harms of those options?”

©PPRNet 2014 PCORI PRIORITIES Research will help answer these questions: “What can I do to improve the outcomes that are most important to me?” “How can clinicians and the care delivery systems they work in help me make the best decisions about my health and healthcare?”

©PPRNet 2014 PPRNET RESEARCH AND THE PCORI VISION –Patient and stakeholder engagement Input on project design Identifying outcomes of interest Monitoring project progress Dissemination of results

©PPRNet 2014 PCORI: ASSESSMENT OF PREVENTION, DIAGNOSIS AND TREATMENT OPTIONS Comparative effectiveness research to: –Inform critical decisions that face patients and caregivers, clinicians, policy makers, and health care system leaders –Decisions occurring now in the absence of sound evidence about the comparative effectiveness of alternative approaches –Substantial potential that patients/caregivers will benefit from the new knowledge in ways that are important to them

©PPRNet 2014 WHAT WE KNOW Cardiovascular disease remains a relevant problem Cholesterol is a key modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD)

©PPRNet 2014 WHAT WE KNOW American College of Cardiology/American Heart Association published revised guideline on the Treatment of Blood Cholesterol (TBC) in late 2013 –Major shift in focus –Emphasis on patient- centered approach –Clinical controversies

©PPRNet 2014 WHAT WE KNOW Statin Benefit Groups (SBGs) Statin Dose Recommendation 1 Patients with clinical ASCVD years of ageHigh-intensity Patients with clinical ASCVD over 75 years of ageModerate-intensity 2 Patients with primary elevations of LDL-C (greater than or equal to 190 mg/dL) High-intensity 3 Patients with diabetes, age years with LDL-C mg/dL, estimated 10-year ASCVD risk less than 7.5% Moderate-intensity Patients with diabetes, age years with LDL-C mg/dL, estimated 10-year ASCVD risk greater than or equal to 7.5% High-intensity 4 Patients with estimated 10-year ASCVD risk of at least 7.5% Patient-centered discussion prior to initiating moderate-to- high intensity*

©PPRNet 2014 ASCVD Risk Reduction Practice-Level Report

©PPRNet 2014 ASCVD Risk Reduction PLR

©PPRNet 2014 WHAT WE DON’T KNOW How to implement a patient- centered approach to discussion of treatment options in “real world” practice What types of practice-based interventions promote patient- centered decision making

©PPRNet 2014 A NEW APPROACH TO PPRNET PROJECTS –Patient and stakeholder engagement Input on project design Identifying outcomes of interest Monitoring project progress Dissemination of results

©PPRNet 2014 CLINICIAN ENGAGEMENT Expressed interest across PPRNet activities Initial survey responses (39 in 10 days!) helped define research question Further input gathered during webinars and calls on what, how of intervention Invited patients to participate in survey

©PPRNet 2014 PATIENT INPUT What matters most to you? “I trust the advice of my doctor” “What it is in my situation that leads the doctor to make such a recommendation” What should your doctor’s role be in helping you make these decisions? “Provide information I can use to self-educate” “I generally ask what the doctor would do in my situation”

©PPRNet 2014 PATIENT INPUT “I lost my father to a massive coronary event at the age of 63 and my sister had a heart attack at 50. I had high cholesterol and with diet and medicine that is now under control. I think the key lies in within our power to prevent.” “Being a patient with diabetes that also receives treatment for high cholesterol this is something very near and dear to my heart.”

©PPRNet 2014 AIMS OF THE PROPOSED PROJECT 1.Compare the impact of a patient-engaged, practice-based intervention to promote patient-centered care (PE-TRIP) to Usual PPRNet Implementation on concordance with the TBC guideline and patient- reported outcomes among 30 PPRNet practices

©PPRNet 2014 AIMS OF THE PROPOSED PROJECT 2. Synthesize “lessons learned” during TBC guideline implementation to identify a set of strategies that promote concordance with the TBC guideline and patient-centered discussions of treatment options in primary care practice

©PPRNet 2014 PROJECT ACTIVITIES All practices: “typical” guideline implementation –Introductory webinar on TBC guideline –Quarterly reports “Patient-engaged” intervention practices +Site visits +“Best practice” meeting + webinars

©PPRNet 2014 PROJECT ACTIVITIES Patient surveys on patient-reported outcomes Focus groups among high performing practices “Patient Partners” to advise research team throughout project

©PPRNet 2014 CHANCES ARE… We will not be funded We need your input on how to position our next wager!

©PPRNet 2014 Recognizing the controversy of the new guidelines and their upcoming anniversary, is this – engaging patients in implementation of new cholesterol guidelines – the “right” topic for a PPRNet PCORI study? –Why? –Why not? ENGAGING CLINICIAN STAKEHOLDERS

©PPRNet 2014 This will be a “Communication and Dissemination Research” proposal. What “gaps” have you experienced in communicating new guideline recommendations to patients and their caregivers? ENGAGING CLINICIAN STAKEHOLDERS

©PPRNet 2014 What tools or strategies would help (or have helped) your practice engage patients in the implementation of the new guidelines? ENGAGING CLINICIAN STAKEHOLDERS

©PPRNet 2014 What PPRNet interventions would help your practice improve implementation of the new guideline? ENGAGING CLINICIAN STAKEHOLDERS

©PPRNet 2014 WHAT NEXT? September 2014Funding decisions October 2014Gather additional patient input Update practice letters of support November 2014 Resubmission

©PPRNet 2014 SUMMARY We are committed to developing “meaningful” PCORI applications and look forward to your input! (See next presentation…)